Keen Vision Acquisition Stock (NASDAQ: KVAC)

Latest news for Keen Vision Acquisition (NASDAQ:KVAC) Stock

Keen Vision Acquisition Corp is a blank check company.

Keen Vision Acquisition Corporation - Ordinary Shares

Keen Vision Acquisition Corp

Keen Vision Acquisition Corporation - Units

Keen Vision Acquisition Corporation - Warrant

WIIM

CHGG

Chegg shares are trading higher after the company announced the repurchase of its 0% convertible senior notes due 2026.

HOOD

Robinhood Markets shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $24 to $55.

<a href="https://www.benzinga.com/topic/compass-pathways">COMPASS Pathways</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>), a key player in the <a href="https://www.benzinga.com/markets/psychedelics">psychedelics industry</a>, recently experienced a $43 million drop in market capitalization, reducing its value to $302 million. As Simply Wall St. <a href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cmps/compass-pathways/news/in-the-wake-of-compass-pathways-plcs-nasdaqcmps-latest-us43m">reported</a>, this decline has placed institutional investors, who own 30% of the company's shares, under increasing pressure to act. The stock has already faced a 32% loss over the past year, raising concerns about its future trajectory.
<h3 class="wp-block-heading">Institutional Ownership And Its Implications</h3>
Institutional investors, often referred to as &#8220;smart money,&#8221; hold the largest stake in COMPASS Pathways. These entities, which include hedge funds owning 13%, are known for their active investment strategies and significant influence on stock prices. A simultaneous sell-off by large institutional shareholders could exacerbate the company's losses, making the current situation pivotal for its stability.
The top nine shareholders collectively own 52% of the company, with George Goldsmith, a co-founder, holding the largest individual stake at 11%. Such concentrated ownership underscores the significant influence these stakeholders wield over the company's future.
<h3 class="wp-block-heading">Insider And Public Stakeholders</h3>
Insiders account for 15% of ownership, valued at $46 million. This level of insider investment suggests a strong alignment of interests between the company&#8217;s leadership and its shareholders. However, balancing the influence of insiders with accountability remains a concern.
The general public holds 25% of COMPASS Pathways, reflecting the involvement of retail investors in the company&#8217;s trajectory. While this group lacks the power to dictate strategy, it plays a critical role in shaping sentiment and trading activity.
<h3 class="wp-block-heading">Private Equity And Strategic Interests</h3>
Private equity firms control 5.6% of COMPASS Pathways, signaling potential for strategic input into the company's operations. Additionally, public companies own 10% of the business, likely reflecting related business interests or a de-merger history, warranting further investigation into these relationships.
<h3 class="wp-block-heading">Broader Implications&nbsp;</h3>
The recent market cap drop highlights the challenges faced by COMPASS Pathways amid broader industry volatility. As institutions weigh their options, the potential for further sell-offs looms, which could negatively impact retail and smaller investors. Analysts will be closely monitoring the company&#8217;s ability to stabilize its earnings trajectory and maintain investor confidence.
Compass shares traded +2.04% at $4.50 per share at the time of this publication early afternoon on Monday.
Cover image made with AI

Cannabis

News

Psychedelics

CMPS

COMPASS Pathways: Institutional Pressure Amid $43M Market Cap Decline, What's Next For This Psychedelics Co?

President-elect Donald Trump's legal troubles are set to ease after Special Counsel Jack Smith formally requested the dismissal of federal charges Monday linked to alleged attempts to overturn the 2020 election.
The move, filed in a Washington federal court Monday, is based on long-standing Justice Department guidance, <a href="https://www.cbsnews.com/">CBS News</a> reports.
What Happened: Smith asked the court to drop the charges against Trump, citing constitutional protections that shield sitting presidents from prosecution. The Justice Department concluded that allowing the case to proceed would conflict with these protections. 
Trump's legal team did not oppose the motion, and the dismissal is expected to be approved before his January inauguration.
Federal prosecutors had accused Trump of attempting to block the transfer of power after losing the 2020 election. The indictment alleged a coordinated effort to challenge the election results and pressure officials to overturn Joe Biden's victory. 
Also Read: <a href="https://www.benzinga.com/general/health-care/24/11/42077935/trump-picks-dr-oz-who-says-seniors-should-give-medical-marijuana-a-try-to-lead-centers-for-medicare-and-medicaid-services">Trump Picks Dr. Oz, Who Says Seniors Should Give Medical Marijuana A Try, To Lead Centers For Medicare And Medicaid Services</a>
Why It Matters: The decision brings an end to one of the most high-profile federal cases against Trump. Critics warn that dropping charges could create a precedent where sitting presidents are shielded from federal accountability. 
Smith, whose investigations also included Trump's handling of classified documents, is expected to resign after submitting a final report.
Trump, meanwhile, <a href="https://www.benzinga.com/news/24/11/42152895/trump-plans-doj-overhaul-including-firing-of-jack-smiths-team">plans sweeping changes</a> to the Department of Justice. Reports suggest he intends to fire Smith's team and revisit allegations of voter fraud, despite repeated findings that such claims lack evidence. Legal experts caution these moves could further erode trust in the Justice Department's impartiality.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42158373/trumps-commerce-secretary-pick-howard-lutnicks-fund-owns-1-19b-in-nvidia-804m-in-tesla-here-is-a-look-at-his-portfolio">Trump&#8217;s Commerce Secretary Pick Howard Lutnick&#8217;s Fund Owns $1.19B In Nvidia, $804M In Tesla: Here Is A Look At His Portfolio</a></li>
</ul>
Photo: Shutterstock.

Politics

Legal

Special Prosecutor In Trump's Jan. 6 Case Asks For Dismissal Ahead Of Inauguration Day

Analysts expect CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) to report third-quarter revenue of $982.36 million <a href="https://www.benzinga.com/earnings">after market close Tuesday.</a> That&#8217;s up from $786.01 million in last year's third quarter, according to data <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112524&amp;t=be2bearmibe3na1">from Benzinga Pro.</a>
Observers will be closely watching the stock for signs of a recovery following a July IT outage — <a href="https://www.benzinga.com/news/24/07/39870313/microsoft-crowdstrike-issue-caused-largest-it-outage-in-history-showing-how-much-we-depend-on-a-hand">one of the largest in history</a>. 
Earnings Estimates: CrowdStrike has beaten analyst revenue estimates in more than 10 straight quarters.
Analysts expect the company to report third-quarter earnings per share of 81 cents, versus 82 cents in last year's third quarter. The company has beaten analyst earnings per share estimates in more than 10 straight quarters.
Guidance<a href="https://www.benzinga.com/news/earnings/24/08/40613150/crowdstrike-q2-earnings-revenue-beat-eps-beat-arr-up-32-even-more-customer-obsessed-company-followi"> from the company</a> calls for third-quarter revenue to be in a range of $979.2 million to $984.7 million. The company also is guiding for third-quarter earnings per share to be in a range of 80 cents to 81 cents per share.
Read Also: <a href="https://www.benzinga.com/markets/equities/24/11/41800177/crowdstrike-expands-cybersecurity-reach-in-europe-and-launches-ai-red-team-services">CrowdStrike Expands Cybersecurity Reach In Europe And Launches AI Red Team Services</a>
What Analysts Are Saying: Investor attention will be on CrowdStrike's recovery from its July 19 outage, Rosenblatt analyst Catherine Trebnick said in a new investor note.
The analyst reiterated a Buy rating and raised the price target from $325 to $385.
"Our channel checks suggest that customers remain confident in the company and are not stepping away," Trebnick said.
Trebnick said CrowdStrike could show "modest upside" from quarterly estimates and raise guidance.
"Some renewals may be delayed, but overall customer retention appears strong."
Guidance and the litigation overhang are key items being watched by WestPark Capital&#8217;s Paul Rodriguez. The analyst has a Hold rating and no price target. Future revenue can be impacted by customer discounts being used to help offset customer complaints about the July outage.
"Our checks suggest CRWD has not suffered much customer churn but CrowdStrike has had to make concessions to its clients base," Rodriguez said.
The analyst said there are concerns about heavy discounting being done in the field.
A litigation overhang mainly revolves around Delta Air Lines, is also a concern for the analyst after Delta decided to move forward with legal action.
"If other companies move further with litigation against CrowdStrike post the Delta news remains to be seen but this scenario does pose a risk to CrowdStrike shares."
Key Items to Watch: CrowdStrike said second-quarter annual recurring revenue was up 32% year-over-year. This remains a key item for investors to watch on Tuesday.
The company said the July outage inspired a renewed focus on becoming a "more customer-obsessed CrowdStrike." 
Cybersecurity remains a key theme going forward with companies increasing focus and spending on this category. Aside from the July outage recovery, new products and commentary on customer spending will be big items to watch for investors.
Price Action: CrowdStrike stock is down 2% to $363.80 on Monday versus a 52-week trading range of $200.81 to $398.30. CrowdStrike stock is up 47% year-to-date.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41803738/invesco-launches-new-etfs-targeting-ai-cybersecurity-and-defense-heres-how-some-of-their-peers-have">Invesco Launches New ETFs Targeting AI, Cybersecurity, And Defense. Here&#8217;s How Some Of Their Peers Have Performed In The Past Year</a></li>
</ul>
Image: Shutterstock

Analyst Color

Price Target

Previews

Reiteration

Analyst Ratings

Trading Ideas

CRWD

CrowdStrike Q3 Earnings Preview: Analysts Anticipate Recovery, 'Customers Remain Confident'

High-rolling investors have positioned themselves bearish on Redfin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in RDFN often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 14 options trades for Redfin. This is not a typical pattern.
The sentiment among these major traders is split, with 35% bullish and 57% bearish. Among all the options we identified, there was one put, amounting to $210,000, and 13 calls, totaling $551,896.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $9.0 and $20.0 for Redfin, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Redfin's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Redfin's whale trades within a strike price range from $9.0 to $20.0 in the last 30 days. 
<h3>Redfin Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732563926_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RDFN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/27/24</td>
<td>$0.7</td>
<td>$0.55</td>
<td>$0.7</td>
<td>$9.00</td>
<td>$210.0K</td>
<td>10</td>
<td>3.0K</td>
</tr>
<tr>
<td>RDFN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$1.9</td>
<td>$1.9</td>
<td>$1.9</td>
<td>$20.00</td>
<td>$114.0K</td>
<td>8.7K</td>
<td>978</td>
</tr>
<tr>
<td>RDFN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.1</td>
<td>$3.9</td>
<td>$3.9</td>
<td>$10.00</td>
<td>$68.2K</td>
<td>3.1K</td>
<td>29</td>
</tr>
<tr>
<td>RDFN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$1.65</td>
<td>$1.6</td>
<td>$1.6</td>
<td>$11.00</td>
<td>$48.0K</td>
<td>1.5K</td>
<td>517</td>
</tr>
<tr>
<td>RDFN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$1.45</td>
<td>$1.4</td>
<td>$1.4</td>
<td>$15.00</td>
<td>$41.8K</td>
<td>1.0K</td>
<td>825</td>
</tr>
</tbody>
</table>

<h3>About Redfin</h3>
Redfin Corp is a residential real estate broker. It pairs its agents with the technology to create a service that is faster and costs less. The company meets customers through a listings-search website and mobile application. The company uses the same combination of technology and local service to originate mortgage loans and offer title and settlement services. It has five operating segments and three reportable segments, real estate services, rentals, and mortgage. The company generates the majority of its revenue from Real estate services.
In light of the recent options history for Redfin, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Redfin</h3>
<ul>
<li>Trading volume stands at 7,177,454, with RDFN's price up by 3.71%, positioned at $9.5.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 92 days.</li>
</ul>
<h3>What The Experts Say On Redfin</h3>
Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $8.8125.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Neutral rating on Redfin with a target price of $8. 
&#x2A; An analyst from Wedbush has decided to maintain their Neutral rating on Redfin, which currently sits at a price target of $10. 
&#x2A; An analyst from Susquehanna persists with their Neutral rating on Redfin, maintaining a target price of $10. 
&#x2A; An analyst from DA Davidson has decided to maintain their Neutral rating on Redfin, which currently sits at a price target of $7. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Redfin options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

RDFN

This Is What Whales Are Betting On Redfin

Financial giants have made a conspicuous bearish move on ONEOK. Our analysis of options history for ONEOK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKE#NYSE">OKE</a>) revealed 10 unusual trades.
Delving into the details, we found 30% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $1,175,640, and 4 were calls, valued at $198,649.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $105.0 to $125.0 for ONEOK during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of ONEOK stands at 201.0, with a total volume reaching 1,759.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in ONEOK, situated within the strike price corridor from $105.0 to $125.0, throughout the last 30 days.
<h3>ONEOK Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732563921_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>OKE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$10.0</td>
<td>$9.6</td>
<td>$9.7</td>
<td>$120.00</td>
<td>$970.0K</td>
<td align="right">59</td>
<td>1.0K</td>
</tr>
<tr>
<td>OKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$16.4</td>
<td>$15.6</td>
<td>$15.8</td>
<td>$105.00</td>
<td>$64.7K</td>
<td align="right">277</td>
<td>42</td>
</tr>
<tr>
<td>OKE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$3.8</td>
<td>$3.7</td>
<td>$3.8</td>
<td>$110.00</td>
<td>$57.0K</td>
<td align="right">383</td>
<td>210</td>
</tr>
<tr>
<td>OKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$8.0</td>
<td>$7.7</td>
<td>$7.9</td>
<td>$110.00</td>
<td>$54.5K</td>
<td align="right">664</td>
<td>105</td>
</tr>
<tr>
<td>OKE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$15.2</td>
<td>$14.8</td>
<td>$15.2</td>
<td>$120.00</td>
<td>$47.1K</td>
<td align="right">0</td>
<td>50</td>
</tr>
</tbody>
</table>

<h3>About ONEOK</h3>
Oneok provides natural gas gathering, processing, storage, and transportation as well as natural gas liquids transportation and fractionation. It owns extensive assets in the midcontinent, Permian, and Rocky Mountain regions.
After a thorough review of the options trading surrounding ONEOK, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is ONEOK Standing Right Now?</h3>
<ul>
<li>With a volume of 4,754,730, the price of OKE is down -5.9% at $110.14. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 91 days.</li>
</ul>
<h3>What The Experts Say On ONEOK</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $108.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on ONEOK with a target price of $107. 
&#x2A; An analyst from Barclays has decided to maintain their Equal-Weight rating on ONEOK, which currently sits at a price target of $99. 
&#x2A; An analyst from Truist Securities has decided to maintain their Hold rating on ONEOK, which currently sits at a price target of $99. 
&#x2A; Maintaining their stance, an analyst from Seaport Global continues to hold a Buy rating for ONEOK, targeting a price of $103. 
&#x2A; An analyst from UBS persists with their Buy rating on ONEOK, maintaining a target price of $132. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest ONEOK options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

A Closer Look at ONEOK's Options Market Dynamics

Deep-pocketed investors have adopted a bearish approach towards Peloton Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTON#NASDAQ">PTON</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in PTON usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 13 extraordinary options activities for Peloton Interactive. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 30% leaning bullish and 38% bearish. Among these notable options, 2 are puts, totaling $139,823, and 11 are calls, amounting to $560,137.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $9.0 to $22.0 for Peloton Interactive over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Peloton Interactive options trades today is 10726.4 with a total volume of 11,942.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Peloton Interactive's big money trades within a strike price range of $9.0 to $22.0 over the last 30 days.
<h3>Peloton Interactive Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732563916_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PTON</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$1.14</td>
<td>$1.1</td>
<td>$1.12</td>
<td>$10.00</td>
<td>$112.0K</td>
<td>63.9K</td>
<td>2.0K</td>
</tr>
<tr>
<td>PTON</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$0.33</td>
<td>$0.3</td>
<td>$0.3</td>
<td>$9.00</td>
<td>$92.7K</td>
<td>5.5K</td>
<td>5.0K</td>
</tr>
<tr>
<td>PTON</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$1.15</td>
<td>$1.1</td>
<td>$1.1</td>
<td>$10.00</td>
<td>$65.5K</td>
<td>63.9K</td>
<td>1.2K</td>
</tr>
<tr>
<td>PTON</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/13/24</td>
<td>$1.04</td>
<td>$1.02</td>
<td>$1.02</td>
<td>$9.00</td>
<td>$56.8K</td>
<td>3.5K</td>
<td>566</td>
</tr>
<tr>
<td>PTON</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$1.14</td>
<td>$1.08</td>
<td>$1.1</td>
<td>$10.00</td>
<td>$55.5K</td>
<td>63.9K</td>
<td>1.2K</td>
</tr>
</tbody>
</table>

<h3>About Peloton Interactive</h3>
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of bike and tread and related accessories sales, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue is generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from the International markets.
In light of the recent options history for Peloton Interactive, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Peloton Interactive's Current Market Status</h3>
<ul>
<li>With a trading volume of 10,526,406, the price of PTON is up by 3.04%, reaching $9.83.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 66 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Peloton Interactive</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $8.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Telsey Advisory Group keeps a Market Perform rating on Peloton Interactive with a target price of $9. 
&#x2A; An analyst from Macquarie has decided to maintain their Neutral rating on Peloton Interactive, which currently sits at a price target of $9. 
&#x2A; An analyst from JP Morgan has decided to maintain their Neutral rating on Peloton Interactive, which currently sits at a price target of $7. 
&#x2A; An analyst from Truist Securities persists with their Hold rating on Peloton Interactive, maintaining a target price of $10. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on Peloton Interactive, which currently sits at a price target of $5. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Peloton Interactive with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

PTON

Peloton Interactive Unusual Options Activity For November 25

The <a href="https://www.benzinga.com/topic/drug-enforcement-administration">Drug Enforcement Administration</a> (DEA) has denied accusations of improper communication with cannabis prohibitionist group Smart Approaches to Marijuana (SAM) during the Biden administration's <a href="https://www.benzinga.com/topic/cannabis-rescheduling">marijuana rescheduling process</a>.
In a recent filing <a href="https://www.marijuanamoment.net/dea-says-it-didnt-conspire-with-anti-marijuana-group-dismissing-allegedly-illegal-talks-as-gossip/">reported</a> by Marijuana Moment, the agency dismissed these allegations as "gossip." While the DEA admitted to the communication, it argued they were no unlawful ex parte and that no harm was done and therefore, the motion by<a href="https://www.benzinga.com/markets/cannabis/24/11/41726679/village-farms-is-only-cannabis-operator-selected-to-represent-weed-industry-at-dea-rescheduling-"> Village Farms International</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) and Hemp for Victory should be dismissed.
<h3 class="wp-block-heading">Allegations Of Misconduct</h3>
Part of the accusations stem from social media posts by SAM president and CEO Kevin Sabet.
In a post May 6, 2024 on X, Sabet admitted to having conversations with &#8220;two confidential sources inside DEA.&#8221; Sabet said these discussions provided inside information about the agency's stance on marijuana rescheduling, including a claim that DEA Administrator Anne Milgram would not approve a proposed rule.
This post was presented as evidence by <a href="https://www.benzinga.com/cannabis">cannabis</a> advocacy groups to support their broader claim that <a href="https://www.benzinga.com/topic/dea-cannabis">the DEA</a> holds a contradictory position, alleging the agency is acting as both judge and participant in the cannabis rescheduling process.
The post by Sabet admitting to the conversations with insider sources is still on X. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">BIG: I can now say with full confidence that the Administrator of DEA, Anne Milgram, did NOT sign the rescheduling order, breaking with five decades of precedent and established law and regulations (two confidential sources inside DEA and another outside DEA with intimate…
&mdash; Kevin Sabet (@KevinSabet) <a href="https://twitter.com/KevinSabet/status/1787569052782846142?ref_src=twsrc%5Etfw">May 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Also: <a href="https://www.benzinga.com/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens">DEA Slammed For Unlawful Talks With Cannabis Opponents &#8211; The Plot Thickens</a>
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.
<h3 class="wp-block-heading">DEA's Defense</h3>
According to the DEA's filing, the cannabis organizations' evidence is not proof of <a href="https://www.benzinga.com/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens">misconduct</a>. &#8220;Movants' own evidence fails to demonstrate that any unlawful ex parte communication took place," the agency said. A movant is any party that makes a motion in a case.
The DEA flatly rejected accusations of bias or impropriety, emphasizing that the submitted evidence amounts to little more than hearsay. 
"The Movants would have this tribunal embark on a fishing expedition in search of evidence to support these sweeping, unsupported claims, which at best can be categorized as gossip, not ex parte communications," the DEA stated.
It also dismissed calls for the <a href="https://www.benzinga.com/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens">agency's removal </a>from the rescheduling process, arguing that there is no legal precedent for such action. 
"The only authority cited by the Movants on this point simply supports the notion that specific individuals may be removed from the proceeding under the appropriate circumstances," per the filing.
Additionally, the DEA pointed out that no misconduct has been alleged against its attorneys involved in the proceedings, further undermining the motion's validity.
As a consequence, the DEA requested the motion's dismissal. "The tribunal correctly questions the seriousness of the remedies sought by the Movants and as such, should deny the motion," the agency concluded. 
Village Farms International is <a href="https://www.benzinga.com/markets/cannabis/24/11/41726679/village-farms-is-only-cannabis-operator-selected-to-represent-weed-industry-at-dea-rescheduling-">the only cannabis operator</a> selected to represent the industry at the<a href="https://www.benzinga.com/markets/cannabis/24/11/41726679/village-farms-is-only-cannabis-operator-selected-to-represent-weed-industry-at-dea-rescheduling-"> </a>upcoming hearing on December 2. 
<ul>
<li>Read Next: <a href="https://www.benzinga.com/24/11/42169153/dea-judge-blocks-researchers-motion-in-cannabis-rescheduling-case">DEA Judge Blocks Researcher&#8217;s Motion In Cannabis Rescheduling Case</a></li>
</ul>
Cover: AI generated image

Government

Regulations

DEA Denies Allegations Of Colluding With Anti-Marijuana Group While Involved In Cannabis Rescheduling Process

ALLY

Ally Financial shares are trading higher after last week's report suggesting the company is assessing the potential sale of its credit card business.

ONEOK shares are trading lower after the company announced plans to acquire the remaining EnLink units in a $4.3 billion stock deal.

Shares of Zoom Video Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) are trading higher Monday. The company is set to release earnings results after the market close. Here&#8217;s what <a href="https://www.benzinga.com/quote/ZM/earnings">you need to know.</a>
What To Know: Zoom Video is due to report third-quarter financial results for fiscal 2025 after the bell. Analysts expect the company to report earnings of $1.31 per share for the quarter, up from $1.29 per share a year ago. Revenue is projected at $1.16 billion, compared to $1.14 billion in the same period last year, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
In the company&#8217;s most-recent quarter, Zoom reported earnings of $1.39 per share, beating the estimate of $1.21 by 14.88%. Revenue came in at $1.16 billion, exceeding expectations and reflecting a 2.09% increase year-over-year.
"In Q2, we outperformed our guidance across the board and grew operating cash flow and free cash flow by 33.7% and 26.2% year over year, respectively, demonstrating our continued commitment to efficient growth," Zoom CEO Eric Yuan said last quarter.
"We also saw strength in large accounts, with customers contributing more than $100,000 in trailing 12 months revenue increasing by 7.1% year over year, and resilience in our Online business, with Online average monthly churn reaching its lowest ever rate.&#8221;
Zoom Video shares have gained nearly 24% since the company last reported earnings. The stock is currently trading at new 52-week highs ahead of earnings. Zoom Video has a 52-week low of $55.06, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. 
Multiple analysts have weighed in on Zoom shares in recent weeks leading up to earnings. Rosenblatt analyst Catharine Trebnick maintained Zoom with a <a href="https://www.benzinga.com/analyst-stock-ratings">Buy rating</a> and price target of $78. Morgan Stanley analyst Meta Marshall maintained an Equal-Weight rating and raised the price target from $68 to $86.
ZM Price Action: Zoom shares were up 3.57% at $88.96 at the time of publication, according to<a href="https://pro.benzinga.com/dashboard"> Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" width="1024" height="540" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25141156/Zm-1024x540.png" alt="" class="wp-image-664052" style="width:454px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25141156/Zm-1024x540.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25141156/Zm-300x158.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25141156/Zm-768x405.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/25141156/Zm.png 1450w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/gaming/24/11/42172580/black-playstation-accessories-may-appear-ahead-of-holiday-season-dealabs">Black PlayStation Accessories May Appear Ahead Of Holiday Season: Dealabs</a></li>
</ul>
Image via Unsplash.

Earnings

Movers

What's Going On With Zoom Video Stock Today?

Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) recent rally could face a sharp downturn, with a prominent trader warning of a potential correction if the cryptocurrency fails to break the <a href="https://www.benzinga.com/news/small-cap/24/11/42171130/russell-2000-dow-sp-500-all-achieve-record-highs-in-wall-streets-historic-day-bitcoin-gold-tumble-whats-driving-markets-monday">$100,000 resistance level.</a>
The <a href="https://x.com/ali_charts/status/1860409141677662707">forecast</a>, which points to a drop as low as $85,600 in a worst-case scenario, comes as Bitcoin shows signs of a cooling rally after nearing the critical $100,000 milestone. 
On Nov. 23, chart analyst Ali Martinez <a href="https://x.com/ali_charts/status/1860409141677662707">flagged</a> a bearish signal on Bitcoin's 12-hour chart using the TD Sequential indicator.
Ali predicted that Bitcoin could correct to $91,583, with a deeper drop to $85,610 if selling pressure intensifies.
The apex crypto is trading around $94,660 at the time of writing, down 1.6% over the past 24 hours.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42171439/solana-meme-coin-platform-pumpfun-faces-backlash-over-scandalous-livestreams-but-polymarket-traders-arent-convinced-theyll-go-dark">Solana Meme Coin Platform Pump.Fun Faces Backlash Over Scandalous Livestreams, But Polymarket Traders Aren&#8217;t Convinced They&#8217;ll Go Dark</a>
Altcoins such as Ripple (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) and Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) are down over 5%, while Solana's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>), Ether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), Cardano's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>) and Binance's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bnb/usd">BNB</a>) fell between 2% and 5%.
This market-wide retreat caused the overall crypto market capitalization to decline by 2.4%.
The volatility also hit crypto-tracked futures, with over $400 million liquidated in both long and short positions.
According to Coinglass <a href="https://www.coinglass.com/LiquidationData">data</a>, $283 million in bullish bets and $156 million in bearish bets were wiped out over the past 24 hours. 
Interestingly, small altcoins and midcap futures saw higher liquidation volumes than Bitcoin and Ether, suggesting increased risk-taking among traders.
The market correction comes against the backdrop of deteriorating sentiment in the cryptocurrency industry as Bitcoin failed to break <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42163156/why-bitcoins-rally-is-stalling-below-100000">the $100,000 threshold</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42170669/wisdomtree-files-for-xrp-etf-trust-report">WisdomTree Files For XRP ETF Trust: Report</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ADA

$BNB

$BTC

$DOGE

$ETH

$SOL

$XRP

Bitcoin Slides Below $95,000 — Analyst Predicts Potential Correction To $85,000

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Hims & Hers Health shares are trading higher. Strength has been attributed to President-elect Donald Trump's plans to nominate Marty Makary to lead the FDA.

Investors with a lot of money to spend have taken a bearish stance on Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with UBER, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 39 uncommon options trades for Uber Technologies.
This isn't normal.
The overall sentiment of these big-money traders is split between 41% bullish and 53%, bearish.
Out of all of the special options we uncovered, 5 are puts, for a total amount of $316,232, and 34 are calls, for a total amount of $2,204,315.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $50.0 to $100.0 for Uber Technologies during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Uber Technologies's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Uber Technologies's whale trades within a strike price range from $50.0 to $100.0 in the last 30 days. 
<h3>Uber Technologies Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732563026_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UBER</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$10.95</td>
<td>$10.85</td>
<td>$10.87</td>
<td>$95.00</td>
<td>$243.8K</td>
<td>635</td>
<td>1.0K</td>
</tr>
<tr>
<td>UBER</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$12.6</td>
<td>$12.3</td>
<td>$12.3</td>
<td>$75.00</td>
<td>$228.9K</td>
<td>3.1K</td>
<td>265</td>
</tr>
<tr>
<td>UBER</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$16.05</td>
<td>$14.65</td>
<td>$15.69</td>
<td>$80.00</td>
<td>$156.9K</td>
<td>343</td>
<td>101</td>
</tr>
<tr>
<td>UBER</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$15.7</td>
<td>$15.4</td>
<td>$15.64</td>
<td>$80.00</td>
<td>$156.4K</td>
<td>343</td>
<td>301</td>
</tr>
<tr>
<td>UBER</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$15.95</td>
<td>$15.4</td>
<td>$15.63</td>
<td>$80.00</td>
<td>$156.3K</td>
<td>343</td>
<td>201</td>
</tr>
</tbody>
</table>

<h3>About Uber Technologies</h3>
Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food delivery service providers, and shippers with carriers. The firm's on-demand technology platform could eventually be used for additional products and services, such as autonomous vehicles, delivery via drones, and Uber Elevate, which, as the firm refers to it, provides "aerial ride-sharing." Uber Technologies is headquartered in San Francisco and operates in over 63 countries with over 150 million users who order rides or food at least once a month.
<h3>Current Position of Uber Technologies</h3>
<ul>
<li>With a volume of 8,625,720, the price of UBER is up 2.51% at $73.31. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 72 days.</li>
</ul>
<h3>What The Experts Say On Uber Technologies</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $93.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Uber Technologies with a target price of $90. 
&#x2A; An analyst from Loop Capital has decided to maintain their Buy rating on Uber Technologies, which currently sits at a price target of $86. 
&#x2A; An analyst from Keybanc has decided to maintain their Overweight rating on Uber Technologies, which currently sits at a price target of $85. 
&#x2A; Maintaining their stance, an analyst from Evercore ISI Group continues to hold a Outperform rating for Uber Technologies, targeting a price of $120. 
&#x2A; An analyst from Gordon Haskett upgraded its action to Buy with a price target of $85. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Uber Technologies, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

UBER

Market Whales and Their Recent Bets on UBER Options

Investors with a lot of money to spend have taken a bullish stance on Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NEM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 10 uncommon options trades for Newmont.
This isn't normal.
The overall sentiment of these big-money traders is split between 70% bullish and 20%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $203,670, and 6 are calls, for a total amount of $800,199.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $30.0 and $60.0 for Newmont, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Newmont options trades today is 3564.38 with a total volume of 5,631.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Newmont's big money trades within a strike price range of $30.0 to $60.0 over the last 30 days.
<h3>Newmont Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732563021_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$3.25</td>
<td>$3.15</td>
<td>$3.24</td>
<td>$45.00</td>
<td>$324.0K</td>
<td>1.3K</td>
<td>1.0K</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$7.5</td>
<td>$7.35</td>
<td>$7.5</td>
<td>$40.00</td>
<td>$269.9K</td>
<td>4.4K</td>
<td>440</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.8</td>
<td>$1.75</td>
<td>$1.8</td>
<td>$42.50</td>
<td>$90.0K</td>
<td>15.2K</td>
<td>944</td>
</tr>
<tr>
<td>NEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$1.1</td>
<td>$0.92</td>
<td>$1.1</td>
<td>$37.50</td>
<td>$84.7K</td>
<td>5.5K</td>
<td>772</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$11.1</td>
<td>$9.9</td>
<td>$11.05</td>
<td>$37.50</td>
<td>$56.1K</td>
<td>130</td>
<td>51</td>
</tr>
</tbody>
</table>

<h3>About Newmont</h3>
Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 17 wholly or majority owned mines and interests in two joint ventures in the Americas, Africa, Australia and Papua New Guinea. The company is expected to produce roughly 5.5 million ounces of gold in 2024 from its core mines and 6.8 million in total. It is likely to sell a number of its higher cost, smaller mines accounting for 20% of forecast sales in 2024. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves along with significant byproduct reserves at the end of December 2023.
<h3>Where Is Newmont Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 5,909,976, with NEM's price down by -2.87%, positioned at $42.13.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 87 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Newmont with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Newmont's Options Frenzy: What You Need to Know

Financial giants have made a conspicuous bearish move on Alnylam Pharmaceuticals. Our analysis of options history for Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) revealed 19 unusual trades.
Delving into the details, we found 5% of traders were bullish, while 84% showed bearish tendencies. Out of all the trades we spotted, 14 were puts, with a value of $931,387, and 5 were calls, valued at $321,410.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $220.0 and $280.0 for Alnylam Pharmaceuticals, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Alnylam Pharmaceuticals stands at 355.17, with a total volume reaching 1,362.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Alnylam Pharmaceuticals, situated within the strike price corridor from $220.0 to $280.0, throughout the last 30 days.
<h3>Alnylam Pharmaceuticals 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732563016_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ALNY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$38.0</td>
<td>$35.6</td>
<td>$38.0</td>
<td>$220.00</td>
<td>$190.0K</td>
<td align="right">262</td>
<td align="right">50</td>
</tr>
<tr>
<td>ALNY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$20.9</td>
<td>$18.5</td>
<td>$19.0</td>
<td>$270.00</td>
<td>$127.3K</td>
<td align="right">601</td>
<td align="right">250</td>
</tr>
<tr>
<td>ALNY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$28.0</td>
<td>$26.9</td>
<td>$28.0</td>
<td>$280.00</td>
<td>$120.4K</td>
<td align="right">312</td>
<td align="right">250</td>
</tr>
<tr>
<td>ALNY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$28.3</td>
<td>$25.2</td>
<td>$28.3</td>
<td>$280.00</td>
<td>$107.5K</td>
<td align="right">312</td>
<td align="right">250</td>
</tr>
<tr>
<td>ALNY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$27.5</td>
<td>$27.4</td>
<td>$27.5</td>
<td>$280.00</td>
<td>$82.5K</td>
<td align="right">312</td>
<td align="right">250</td>
</tr>
</tbody>
</table>

<h3>About Alnylam Pharmaceuticals</h3>
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
After a thorough review of the options trading surrounding Alnylam Pharmaceuticals, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Alnylam Pharmaceuticals</h3>
<ul>
<li>With a volume of 460,809, the price of ALNY is up 3.96% at $254.59. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 80 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Alnylam Pharmaceuticals, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

ALNY

Check Out What Whales Are Doing With ALNY

The Benzinga Future of Digital Assets event featured a panel on NFTs and the metaverse, sparking discussions about their long-term potential despite current skepticism. Post panel, <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42138947/bitcoin-zeroes-in-on-100000-but-this-indicator-signals-one-more-brief-correction">Ian Horne, head of content </a>for Money20/20 Amsterdam, shared his perspective on how these technologies may evolve and gain broader acceptance over time.
<h1 class="wp-block-heading">Moving Beyond Skepticism</h1>
Horne acknowledged the criticism NFTs and the metaverse have faced in recent years, often due to unrealistic expectations and failed projects. But, he argued that their core concepts remain relevant for the future of digital interaction.
"These concepts have been derided rightly for failures in recent years," Horne said, "but long term, the idea of a metaverse becoming a thriving idea, and NFTs being important to identity and how we relate to others online, is completely still valid."
The panel conversation, which included Alex Salnikov of Rarible, delved into how practical applications of NFTs and metaverse technology could reshape online experiences. Horne emphasized that discussing these ideas in a grounded way helps audiences better understand their potential.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42138947/bitcoin-zeroes-in-on-100000-but-this-indicator-signals-one-more-brief-correction">Bitcoin Zeroes In On $100,000, But This Indicator Signals One More Brief Correction</a>
<h1 class="wp-block-heading">Adoption Through Integration</h1>
Addressing skepticism, Horne explained that widespread adoption of these technologies would likely happen when seamlessly integrated into daily activities without being labeled as NFTs or metaverse applications. 
"I think the real adoption of these things is going to happen when we don't talk about it like it being the metaverse or like it being an NFT," he said. Instead, users will engage with digital tools like tokens or online marketplaces without understanding the underlying technology.
Horne stressed the focus should shift to the value these technologies add rather than their technical definitions. "When we're talking about the value add and not the technology, that's when I think we're nailing it," he added.
The panel discussion at the event reflected a broader sentiment that while challenges remain, the long-term promise of NFTs and the metaverse lies in their ability to integrate seamlessly into the digital world and shape how individuals interact online.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42138209/microstrategy-trading-at-insane-256-premium-to-bitcoin-holdings-research-shows">MicroStrategy Trading At &#8216;Insane&#8217; 256% Premium To Bitcoin Holdings, Research Shows</a></li>
</ul>
Photo by Corynn Egreczky.

Events

Exclusives

Interview

NFTs, Metaverse 'Derided Rightly,' But Experts See Bright Future Ahead

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 400 points on Monday.
The Dow traded up 0.95% to 44,718.05 while the NASDAQ rose 0.25% to 19,050.84. The S&amp;P 500 also rose, gaining, 0.29% to 5,986.39.
Check This Out: <a href="https://www.benzinga.com/24/11/42137942/jim-cramer-says-this-stock-is-a-bitcoin-play-and-he-prefers-to-own-bitcoin">Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin</a>
Leading and Lagging Sectors Consumer discretionary shares jumped by 1.6% on Monday.
In trading on Monday, energy shares fell by 1.8%.
Top Headline
The Dallas Fed&#8217;s Texas manufacturing activity index rose to -2.7 in November compared to a reading of -3 in the previous month and versus market estimates of -2.4.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>BridgeBio Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIO#NASDAQ">BBIO</a>) shares shot up 19% to $27.80 after the company announced that the FDA approved Attruby to treat adults with ATTR-CM.</li>
<li>Shares of Quantum Computing Inc. &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) got a boost, surging 12% to $6.80 after AWS announced Quantum Embark program.</li>
<li>Rigetti Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) shares were also up, gaining 56% to $2.7211 after the company completed a $100 million at-the-market equity offering, with plans to use the proceeds for working capital, capital expenditures, and advancements in superconducting quantum computing technology.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Cassava Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) shares dropped 81% to $4.7301 after the company announced Simufilam did not show a significant reduction in cognitive or functional decline versus placebo in patients with mild-to-moderate Alzheimer&#8217;s disease in the ReThink-ALZ Phase 3 study.</li>
<li>Shares of Oncternal Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCT#NASDAQ">ONCT</a>) were down 46% to $0.6201 after the company announced that NASDAQ plans to delist its stock.</li>
<li>CareMax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMAX#NASDAQ">CMAX</a>) was down, falling 14% to $0.6205 after the company announced restructuring amidst its bankruptcy and delisting challenges.</li>
</ul>
Commodities In commodity news, oil traded down 3.3% to $68.92 while gold traded down 3.4% at $2,621.10.
Silver traded down 3.4% to $30.265 on Monday, while copper rose 0.2% to $4.0925.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.06%, Germany's DAX gained 0.43% and France's CAC 40 rose 0.03%. Spain's IBEX 35 Index rose 0.47%, while London's FTSE 100 gained 0.36%.
The Ifo Business Climate indicator for Germany fell to 85.7 in November compared to 86.5 in October and down from market expectations of 86. Producer prices in Spain fell by 3.9% year-over-year in October.
Asia Pacific Markets
Asian markets closed mixed on Monday, with Japan's Nikkei 225 gaining 1.30%, Hong Kong's Hang Seng Index falling 0.41%, China's Shanghai Composite Index falling 0.11% and India's BSE Sensex gaining 1.25%.
Economics
<ul>
<li>The Chicago Fed National Activity Index fell to -0.40 in October compared to -0.27 in the previous month and versus market estimates of -0.20.</li>
<li>The Dallas Fed&#8217;s Texas manufacturing activity index rose to -2.7 in November compared to a reading of -3 in the previous month and versus market estimates of -2.4.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42163921/top-3-real-estate-stocks-that-may-explode-in-q4">Top 3 Real Estate Stocks That May Explode In Q4</a></li>
</ul>

Equities

Eurozone

Commodities

Intraday Update

BBIO

CMAX

ONCT

QUBT

RGTI

SAVA

Gold Down Over 3%; Rigetti Computing Shares Spike Higher

<a href="https://www.wsj.com/business/media/nbc-ready-to-pay-triple-to-gobble-up-thanksgiving-parade-broadcast-rights-e18fd95f?mod=latest_headlines" title="https://www.wsj.com/business/media/nbc-ready-to-pay-triple-to-gobble-up-thanksgiving-parade-broadcast-rights-e18fd95f?mod=latest_headlines">https://www.wsj.com/business/media/nbc-ready-to-pay-triple-to-gobble-up-thanksgiving-parade-broadcast-rights-e18fd95f?mod=latest_headlines</a>

CMCSA

'NBC, Macy's Near Pact That Would Triple Fees For Broadcasting Thanksgiving Parade; Macy's Parade's Average Annual Fee Would Increase To $60 Million Under New Terms' - WSJ

Keen Vision Acquisition Corporation (KVAC) has shared an announcement. Professor LI, Ronald Adolphus stepped down from his roles on the board and v...

Keen Vision Acquisition Corp Announces Board Reshuffle

Keen Vision Acquisition Corporation ( ($KVAC) ) has shared an announcement. Keen Vision Acquisition Corporation (KVAC) has entered into a merger ag...

Keen Vision Merges with Biotech Medera, Eyes NASDAQ Listing

KVAC

Press Releases

Medera Inc. to be Listed on NASDAQ Through a Merger Agreement with Keen Vision Acquisition Corporation

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KVAC, CNOB, FLIC on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CNOB, FLIC, KVAC on Behalf of Shareholders

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Keen Vision Acquisition Corp. - KVAC

Medera Announces Completion of Cohort A and Initiation of Dosing in Cohort B of MUSIC-HFpEF, a Phase 1/2a Clinical Trial Evaluating First-In-Human Gene Therapy SRD-002 for Heart Failure with Preserved Ejection Fraction

Medera Announces Publication of Study Utilizing Machine Learning to Enhance Next-Generation Drug Screening with Human mini-Heart Technology

CNOB

CNOBP

FLIC

KVACU

Keen Vision Acquisition

<ul><li>Traditional methods for evaluating therapeutic efficacy and cardiotoxicity often lead to high failure rates during clinical trials, resulting in significant development costs &nbsp;</li><li>Human-specific diseases cannot be accurately modeled by animals, leading to limited medical options or advancements &nbsp;</li><li>This new study leverages the capabilities of artificial intelligence (AI) and machine learning (ML) to address the challenge of achieving automated and comprehensive "smart" drug screening using Medera's mini-Heart technology platform &nbsp;</li><li>Innovative AI/ML-based model combines data from multiple human mini-Heart screening assays and takes advantage of the complementary strengths to achieve superior next-generation drug classification capabilities &nbsp;</li><li>The unique combination of AI/ML and human mini-Hearts can accelerate drug discovery, clinical translation and precision medicine by improving screening efficiency, reducing costs, enhancing safety and creating new opportunities for patient benefits</li></ul>SUMMIT, N.J. and BOSTON, Mass., Oct. 31, 2024 /PRNewswire/ --&nbsp;Medera Inc. ("Medera"), a clinical-stage biotechnology company focused on targeting difficult-to-treat cardiovascular diseases using a range of next-generation gene- and cell-based approaches, announced today the <a href="https://www.sciencedirect.com/science/article/pii/S1043661824004043">publication</a>&nbsp;of a new study in the peer-reviewed journal Pharmacological Research (volume 209). This study, entitled "Enhanced Drug Classification Using Machine Learning with Multiplexed Cardiac Contractility Assays," demonstrates how Novoheart, Medera's wholly-owned preclinical subsidiary focused on human cardiovascular disease modeling for drug discovery, is leveraging AI and ML to improve next-generation drug screening processes.

Biotech

General

Medera Announces Publication Of Study Utilizing Machine Learning To Enhance Next-Generation Drug Screening With Human Mini-Heart Technology

<ul><li>Medera is a clinical-stage biotechnology company focused on targeting difficult-to-treat cardiovascular diseases using a range of next-generation gene- and cell-based approaches in combination with bioengineered human mini-heart drug discovery and screening technology platforms</li><li>Transaction proceeds to accelerate three most advanced clinical programs for the adeno-associated virus (AAV)-based gene therapy candidates</li><li>The combined company to have an implied initial enterprise value of approximately $622.6 million</li><li>Medera's founders and key shareholders have committed approximately $22.6 million (via conversion of all shareholders loans) for this merger, with all existing Medera shareholders rolling 100% of their equity</li><li>As a closing condition to the business combination, Medera shall have at least $40 million in available liquidity</li><li>Anticipated closing of transaction in fourth quarter of 2024</li></ul>SUMMIT, N.J. and BOSTON, Sept. 5, 2024 /PRNewswire/ -- Keen Vision Acquisition Corporation ("KVAC") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KVAC#NASDAQ">KVAC</a>, KVACW))))) and Medera Inc., ("Medera"), a clinical-stage biotechnology company, announced today that they have entered into a definitive merger agreement. Upon closing of the merger, which is expected to occur in the fourth quarter&nbsp;of 2024, the combined company is to be named Medera Inc.

Comments

Keen Vision Acquisition

News

Latest news for Keen Vision Acquisition (NASDAQ:KVAC) Stock

Thursday, October 31, 2024

Thursday, September 05, 2024

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga